[HTML][HTML] Adeno-associated virus (AAV) as a vector for gene therapy

MF Naso, B Tomkowicz, WL Perry III, WR Strohl - BioDrugs, 2017 - Springer
There has been a resurgence in gene therapy efforts that is partly fueled by the identification
and understanding of new gene delivery vectors. Adeno-associated virus (AAV) is a non …

[HTML][HTML] Various AAV serotypes and their applications in gene therapy: an overview

SS Issa, AA Shaimardanova, VV Solovyeva… - Cells, 2023 - mdpi.com
Despite scientific discoveries in the field of gene and cell therapy, some diseases still have
no effective treatment. Advances in genetic engineering methods have enabled the …

[HTML][HTML] Adeno-associated virus capsid assembly is divergent and stochastic

TP Wörner, A Bennett, S Habka, J Snijder… - Nature …, 2021 - nature.com
Adeno-associated viruses (AAVs) are increasingly used as gene therapy vectors. AAVs
package their genome in a non-enveloped T= 1 icosahedral capsid of~ 3.8 megaDalton …

Applications of charge detection mass spectrometry in molecular biology and biotechnology

MF Jarrold - Chemical reviews, 2021 - ACS Publications
Charge detection mass spectrometry (CDMS) is a single-particle technique where the
masses of individual ions are determined from simultaneous measurement of their mass-to …

[HTML][HTML] The AAV vector toolkit: poised at the clinical crossroads

A Asokan, DV Schaffer, RJ Samulski - Molecular Therapy, 2012 - cell.com
The discovery of naturally occurring adeno-associated virus (AAV) isolates in different
animal species and the generation of engineered AAV strains using molecular genetics …

[HTML][HTML] Twenty-five years of structural parvovirology

M Mietzsch, JJ Pénzes, M Agbandje-McKenna - Viruses, 2019 - mdpi.com
Parvoviruses, infecting vertebrates and invertebrates, are a family of single-stranded DNA
viruses with small, non-enveloped capsids with T= 1 icosahedral symmetry. A quarter of a …

[HTML][HTML] Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector

DE Bowles, SWJ McPhee, C Li, SJ Gray, JJ Samulski… - Molecular Therapy, 2012 - cell.com
Efficient and widespread gene transfer is required for successful treatment of Duchenne
muscular dystrophy (DMD). Here, we performed the first clinical trial using a chimeric adeno …

Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates

PX Wang, YX Ji, XJ Zhang, LP Zhao, ZZ Yan… - Nature medicine, 2017 - nature.com
Nonalcoholic steatohepatitis (NASH) is a progressive disease that is often accompanied by
metabolic syndrome and poses a high risk of severe liver damage. However, no effective …

[HTML][HTML] Recent progress and considerations for AAV gene therapies targeting the central nervous system

EA Lykken, C Shyng, RJ Edwards, A Rozenberg… - Journal of …, 2018 - Springer
Background Neurodevelopmental disorders, as a class of diseases, have been particularly
difficult to treat even when the underlying cause (s), such as genetic alterations, are …

The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis

P Zhang, PX Wang, LP Zhao, X Zhang, YX Ji… - Nature medicine, 2018 - nature.com
Activation of apoptosis signal-regulating kinase 1 (ASK1) in hepatocytes is a key process in
the progression of nonalcoholic steatohepatitis (NASH) and a promising target for treatment …